Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or Obese
Clinical trial NCT05511025 · COMPLETED
Trial details
- NCT number
- NCT05511025
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-20
- Primary completion
- 2023-12-19
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.